Growth Hormone Optimization
Protocol 02 of 12

โšก CJC-1295 / Ipamorelin

GH Secretagogue Stack

CJC-1295 and Ipamorelin are almost always prescribed together โ€” and for good reason. They work through different but complementary mechanisms to produce a more robust, sustained growth hormone pulse than either can achieve alone.

Anti-AgingLean MuscleFat MetabolismRecovery
๐Ÿ“… Schedule a Consultation โ†’
Protocol at a glance
Administration
Subcutaneous injection
Frequency
5 nights per week (before bed)
Typical Duration
3โ€“6 months
Best For
Body composition, anti-aging, recovery
Supervision
Physician required
Ready to learn more?
Download the free STL Peptide Guide or schedule a consultation to discuss whether this protocol is right for you.
Get the Free Guide
The Science

Two signals. One outcome.

CJC-1295 is a GHRH (growth hormone-releasing hormone) analog. It binds to GHRH receptors in the pituitary gland and extends the duration of the signal that prompts GH release. On its own, it produces a broader, more sustained elevation in growth hormone output.

Ipamorelin is a growth hormone secretagogue that works through the ghrelin receptor (GHSR). It triggers a sharp, selective pulse of GH release. Crucially, it does this with minimal effect on cortisol and prolactin โ€” which matters because many older GH secretagogues produced significant cortisol elevation as a side effect. Ipamorelin avoids that, giving you a much cleaner hormonal profile.

Combined, you get the broad sustained effect of CJC-1295 and the sharp selective pulse of Ipamorelin โ€” a synergy that produces more GH output than either peptide alone. Both are signaling agents: they're telling your pituitary to release more of its own GH, not adding exogenous growth hormone to the system.


Who It's For

For anyone optimizing from the inside out.

This combination is one of the most widely prescribed peptide protocols for a reason. The effects of optimized GH levels touch a lot of things people care about: body composition, recovery speed, sleep quality, skin, and the general sense of physical vitality that tends to decline with age.

Patients who benefit most are typically in the 35โ€“65 age range, when natural GH output has meaningfully declined but the pituitary still has capacity to produce more given the right signal. It's not appropriate for patients with active cancer or a history of certain cancers, and baseline IGF-1 labs are essential before starting.

  • Lean muscle support and body recomposition
  • Improved fat metabolism
  • Faster recovery from training
  • Sleep quality improvement
  • Skin, hair, and collagen effects
  • General anti-aging and vitality

Protocol

Simple, consistent, effective.

This stack is typically administered as a subcutaneous injection 5 nights per week, taken before bed. The timing is intentional โ€” GH is naturally released in pulses during deep sleep, and taking the peptides before bed amplifies this natural pulse rather than disrupting it.

Most protocols run 3โ€“6 months, with a reassessment of IGF-1 levels at the midpoint and end. Some patients cycle off for a period and return; others stay on longer-term with periodic breaks. The approach depends on your goals, your labs, and how your body responds.

GoalTypical DurationMonitoring
Body composition3โ€“6 monthsIGF-1 at baseline + 3mo
Anti-aging / vitality6+ months (with breaks)IGF-1, fasting glucose
Recovery optimization3 monthsClinical assessment
Sleep improvement6โ€“12 weeksSymptom-based

Side Effects

What you should know

The most common side effects are water retention in the first few weeks โ€” usually in the hands and feet โ€” and occasional headaches or fatigue. These typically resolve as the body adjusts.

Some patients experience a mild tingling or numbness in the extremities, especially in the early weeks. This is generally harmless and resolves with dose adjustment if needed.

More substantively: elevated IGF-1 has a theoretical association with cell proliferation, which is why baseline and follow-up labs are not optional. We take this seriously. Patients with active malignancy or a history of cancer are not candidates for this protocol.


Frequently Asked Questions

Common questions about CJC-1295 / Ipamorelin

How is this different from actual HGH injections?

Exogenous HGH directly adds growth hormone to your system. This protocol tells your pituitary to produce more of its own. The practical result can be similar, but the mechanism is fundamentally different โ€” and many physicians prefer the signaling approach because it works within your body's own regulatory feedback loops rather than bypassing them.

Will I notice a difference in sleep?

Many patients report improved sleep quality as one of the first noticeable effects, often within the first 2โ€“4 weeks. This makes sense given that GH is naturally secreted during deep sleep phases.

Does this work for women too?

Yes. GH decline happens in both sexes, and the benefits โ€” body composition, recovery, skin, energy โ€” are relevant regardless of sex. Dosing may be adjusted.

Why before bed?

Growth hormone is released in pulses, the largest of which occurs during deep sleep. Timing the injection to coincide with this natural window amplifies the effect rather than creating an out-of-phase signal.


STL Peptide Clinic ยท St. Louis, MO
Ready to discuss whether CJC-1295 / Ipamorelin is right for you?

We review your labs, goals, and health history before recommending any protocol. Available in-person in St. Louis or via secure telehealth.

๐Ÿ“… Request a Consultation โ†’
(314) 492-8700 ยท stlpeptideclinic.com

โš ๏ธ All protocols require a physician consultation and are prescribed based on individual clinical evaluation. This page is for educational purposes only and does not constitute medical advice.

Free Peptide Guide

32-page physician-authored guide covering all 12 protocols, lab recommendations, and what to expect.

Download Free โ†’